Cargando…
PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076010/ https://www.ncbi.nlm.nih.gov/pubmed/35522941 http://dx.doi.org/10.1002/ctm2.754 |
| _version_ | 1784701815588126720 |
|---|---|
| author | Mu, Songlin Liang, Zhijuan Wang, Yongmei Chu, Wendi Chen, Yi‐Li Wang, Qi Wang, Guifeng Wang, Chunhe |
| author_facet | Mu, Songlin Liang, Zhijuan Wang, Yongmei Chu, Wendi Chen, Yi‐Li Wang, Qi Wang, Guifeng Wang, Chunhe |
| author_sort | Mu, Songlin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9076010 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90760102022-05-13 PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model Mu, Songlin Liang, Zhijuan Wang, Yongmei Chu, Wendi Chen, Yi‐Li Wang, Qi Wang, Guifeng Wang, Chunhe Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-05-06 /pmc/articles/PMC9076010/ /pubmed/35522941 http://dx.doi.org/10.1002/ctm2.754 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Mu, Songlin Liang, Zhijuan Wang, Yongmei Chu, Wendi Chen, Yi‐Li Wang, Qi Wang, Guifeng Wang, Chunhe PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
| title | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
| title_full | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
| title_fullStr | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
| title_full_unstemmed | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
| title_short | PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model |
| title_sort | pd‐l1/tigit bispecific antibody showed survival advantage in animal model |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076010/ https://www.ncbi.nlm.nih.gov/pubmed/35522941 http://dx.doi.org/10.1002/ctm2.754 |
| work_keys_str_mv | AT musonglin pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT liangzhijuan pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT wangyongmei pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT chuwendi pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT chenyili pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT wangqi pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT wangguifeng pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel AT wangchunhe pdl1tigitbispecificantibodyshowedsurvivaladvantageinanimalmodel |